Brian Erler

Papers

Total Citations

H-Index

About

Brian Erler is a gynecologic oncologist whose research focuses on refining surgical staging and intraoperative assessment for endometrial cancer. His work addresses critical challenges in determining the risk of lymph node spread, directly impacting treatment decisions and patient outcomes. Erler’s 2020 study on intraoperative evaluation of endometrial cancer—cited 10 times—prospectively validated the Mayo Clinic’s four-criteria model (histopathology, grade, tumor size, and myometrial invasion depth), providing a framework to predict nodal metastasis and guide the need for lymphadenectomy. This contribution helps surgeons avoid unnecessary lymph node dissection in low-risk patients while ensuring high-risk cases receive appropriate staging. In a 2021 study, Erler evaluated sentinel lymph node (SLN) sampling using indocyanine green dye with near-infrared detection during robot-assisted surgery, demonstrating its technical simplicity and sensitivity in endometrial cancer staging. By advancing minimally invasive, targeted approaches, his work supports the shift toward precision surgery that reduces morbidity without compromising oncologic safety. Erler’s research bridges pathology and surgical innovation, offering practical tools for intraoperative decision-making and improving the standard of care in gynecologic oncology.